Factors associated with anti-drug antibody production in ankylosing spondylitis patients treated with the infliximab biosimilar CT-P13
Smoking is identified as a significant risk factor for elevated ADAs in AS patients treated with CT-P13. The findings underscore the importance of smoking-cessation strategies in the management of AS patients.
Authors
- Ji-Hui Shin
- Bora Nam (ORCID: https://orcid.org/0000-0003-0215-3855)
- Y.B. Kim (ORCID: https://orcid.org/0009-0006-6333-0535)
- Sungsin Jo (ORCID: https://orcid.org/0000-0003-3034-5029)
- Tae‐Hwan Kim (ORCID: https://orcid.org/0000-0002-3542-2276)
- Nayeon Choi (ORCID: https://orcid.org/0000-0001-8925-3714)
Institutions
- Soonchunhyang University (KR)
- Hanyang University Seoul Hospital (KR)
- Biostatistical Consulting (United States) (US)
- Hanyang University (KR)
Publication Details
- Journal
- Journal of Rheumatic Diseases
- Published
- 2025-01-16
- DOI
- https://doi.org/10.4078/jrd.2024.0114
- Citations
- 3
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 2.39
Funders
- Hanyang University